{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:14:43Z","timestamp":1789719283833,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/mbc.0000000000000293","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T17:46:18Z","timestamp":1428083178000},"page":"448-453","source":"Crossref","is-referenced-by-count":20,"title":["Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms"],"prefix":"10.1097","volume":"26","author":[{"given":"Jarmila","family":"Kissova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Ovesna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Bulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Zav\u0159elova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Penka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-16-20210203","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties.","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb Res"},{"key":"R2-16-20210203","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism.","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb Res"},{"key":"R3-16-20210203","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCRESAHA.110.233403","article-title":"Leukocyte-derived microparticles in vascular homeostasis.","volume":"110","author":"Angelilo-Scherre","year":"2012","journal-title":"Circ Res"},{"key":"R4-16-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","article-title":"Cellular mechanism underlying the formation of circulating microparticles.","volume":"31","author":"Morel","year":"2011","journal-title":"Arterioscler Thromb Vas Biol"},{"key":"R5-16-20210203","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.110.226456","article-title":"Microparticles: protagonist of a novel communication network for intercellular information Exchange.","volume":"107","author":"Mause","year":"2010","journal-title":"Circ Res"},{"key":"R6-16-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/s-0028-1104547","article-title":"Microparticles in health and disease.","volume":"34","author":"Enjeti","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"R7-16-20210203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1160\/TH10-09-0595","article-title":"Preanalytical and analytical issues in the analysis of blood microparticles.","volume":"105","author":"Yuana","year":"2011","journal-title":"Thromb Haemost"},{"key":"R8-16-20210203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"R9-16-20210203","first-page":"163","article-title":"Czech Working Group of the Czech Hematologic Society CLS JEP. Summary of recommendations for the diagnosis and therapy of BCRABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP.","volume":"58","author":"Penka","year":"2012","journal-title":"Vnitr Lek"},{"key":"R10-16-20210203","first-page":"189","article-title":"Diagnosis and treatment of BCRABL-negative myeloproliferative diseases-principles and rationale of CZEMP recommendations.","volume":"57","author":"Schwarz","year":"2011","journal-title":"Vnitr Lek"},{"key":"R11-16-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation.V2012.1.571.3798557","article-title":"Thrombotic disease in the myeloproliferative neoplasms.","volume":"2012","author":"Falanga","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R12-16-20210203","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders.","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"R13-16-20210203","first-page":"561","article-title":"The spectrum of JAK2-positive myeloproliferative neoplasms.","volume":"2012","author":"Kiladjian","year":"2012","journal-title":"Haematologica"},{"key":"R14-16-20210203","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders.","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-16-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49488 individuals from the general population.","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br J Haematol"},{"key":"R16-16-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3324\/haematol.13869","article-title":"Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.","volume":"94","author":"De Stefano","year":"2009","journal-title":"Haematologica"},{"key":"R17-16-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2141.2005.05858.x","article-title":"The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia.","volume":"132","author":"Cheung","year":"2006","journal-title":"Br J Haematol"},{"key":"R18-16-20210203","first-page":"775","article-title":"What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia and what can be the predictive sign of the risk of thrombosis in such patients: a report from the registry of patients treated by Thromboreductine.","volume":"54","author":"Penka","year":"2008","journal-title":"Vnitr Lek"},{"key":"R19-16-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia.","volume":"2","author":"Briere","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R20-16-20210203","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"key":"R21-16-20210203","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1100\/tsw.2011.108","article-title":"Defining thrombotic risk in patients with myeloproliferative neoplasms.","volume":"11","author":"Vianello","year":"2011","journal-title":"Sci World J"},{"key":"R22-16-20210203","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3324\/haematol.2009.013375","article-title":"Blood cell activation in myeloproliferative neoplasms.","volume":"94","author":"Cervantes","year":"2009","journal-title":"Haematologica"},{"key":"R23-16-20210203","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/leu.2011.306","article-title":"How to manage essential thrombocythemia.","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"key":"R24-16-20210203","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3324\/haematol.2010.038299","article-title":"Pathophysiology of thrombosis in myeloproliferative neoplasms.","volume":"96","author":"Landolfi","year":"2011","journal-title":"Haematologica"},{"key":"R25-16-20210203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2V617F allele burden.","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am J Hematol"},{"key":"R26-16-20210203","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3324\/haematol.13774","article-title":"Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.","volume":"94","author":"Trappenburg","year":"2009","journal-title":"Haematologica"},{"key":"R27-16-20210203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.thromres.2010.06.025","article-title":"Increased circulating procoagulant activity and trombin generation in patients with myeloproliferative neoplasms.","volume":"126","author":"Duchemin","year":"2010","journal-title":"Thromb Res"},{"key":"R28-16-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:23:20Z","timestamp":1620959000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201506000-00016"}},"subtitle":["a single-centre experience"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000293","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}